Dr. Christiane Smerling, 3B Pharmaceuticals GmbH Berlin:

3B Pharmaceuticals is a pharmaceutical R&D company operating in the area of peptide drug development. Dr. Christiane Smerling is Head of the Division Nuclear Medicine & Imaging.

"We have been entrusting Trenzyme for over a year with protein production and purification projects from various host organisms such as mammalian cells and E.coli. Throughout the entire collaboration, Trenzyme has been a reliable, flexible, and innovative outsourcing partner. I particularly appreciate Trenzyme's scientific competence and their proactive communication during our collaboration, and I certainly hope that we will continue this collaboration in the years to come."

Prof. Dr. R.G. Clerc, Hoffmann-LaRoche Ltd Basel:

"No need to take the pipet in hand while relying on Trenzyme!"

Dr. A. Chambovey, Actelion Ltd Allschwil:

"Always a pleasure to work with! Professional, friendly, customer oriented, communicative and competent!"

PD Dr. D. Wicher, Max Planck Institute for Chemical Ecology:

"We were astonished by Trenzyme's recently delivered custom ExoIN cell lines. Even "difficult-to-express" constructs show stable and robust expression. I highly recommend Trenzyme's cell line development service."

Dr. R. Lange, Actelion Ltd Allschwil:

"We highly appreciate the collaboration with Trenzyme on account of the following reasons: Trenzyme provides/delivers high quality material and services; gives excellent advice. Trenzyme has and 'outstanding' team, skilled and professional. Direct and uncomplicated communication."

Dr. L. Knirsch, Nycomed Konstanz:

"Quick turn around time."